COSA is a web-based clinical drug information reference for physicians and healthcare professionals.
The App DNA
What makes this app unique?
The service provides a professional-grade clinical data source that functions as an acquisition channel for the Physicians Office Resource platform.
For Physicians and healthcare professionals requiring clinical drug information.
What does it look like?
Key features
Clinical data licensed from First DataBank using the National Drug Data File standard.
Retrieval of clinical information and patient resources by drug name or manufacturer.
How much does it cost?
The service acts as a lead-generation hook for the broader Physicians Office Resource professional platform.
Velocity
Dormant developmentUX improvementsShow more...
COSA: Medication Information has been inactive for 572 days, placing it firmly in the zombie category. The development cycle has ceased, with no updates or feature additions provided to users in over a year and a half. The last recorded activity was a minor update to the drug page overview, and there is no evidence of ongoing maintenance or support.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for COSA: Medication Information
How's the Medical market?
COSA functions as a professional reference tool, anchored by a 3.67-star rating across a small sample of three reviews. The lack of updates since February 2025 signals a maintenance-only posture relative to active clinical reference competitors.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for COSA: Medication Information
Where is it heading?
The clinical reference market is consolidating around platforms that integrate real-time data updates and patient-facing workflows. COSA remains a static acquisition channel, which will likely see declining professional engagement if the data-refresh cadence does not align with industry standards.
- The 19-month development gap indicates a maintenance-only posture, which limits the potential for professional user growth.
The SWOT
- Clinical data integrity via First DataBank licensing
- Patient-facing adherence tools could increase platform stickiness
Next best moves
Audit clinical data currency because the 19-month update gap risks professional trust → maintain reference utility
The counter-intuitive read
The 19-month update silence is a feature, not a bug…
Read the full takeSince the last report: The platform has shifted its market positioning from a general professional utility to a defined static acquisition channel for the Physicians Office Resource network. This change formalizes the impact of the 19-month development silence on its competitive standing.
Bottom line
COSA functions as a stable lead-generation hook for the Physicians Office Resource platform, but the lack of active development risks professional attrition as competitors refresh clinical data interfaces more frequently.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated